about
Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy.Induced pluripotent stem cell models of lysosomal storage disorders.The Spectrum of Neurological Manifestations Associated with Gaucher Disease.Endoplasmic Reticulum Malfunction in the Nervous System.Ferroportin disease: pathogenesis, diagnosis and treatment.Dysregulation of autophagy as a common mechanism in lysosomal storage diseases.ACE phenotyping in Gaucher disease.A chemical genetic screen reveals that iminosugar inhibitors of plant glucosylceramide synthase inhibit root growth in Arabidopsis and cereals
P2860
Q33443605-7316AB96-FBDB-4E68-8D2A-8152B22D4294Q33830512-C0977E47-9FCE-4E8C-998E-935D4240C47EQ42136746-EB671866-8043-4FD7-A55B-ECB462DA2237Q42290598-AEB2323A-E45F-4A65-8170-CA709BA3DEE8Q47109362-CA5A34B8-4DCF-4370-ACBC-FC4CF8F36A84Q47321665-39A8D3CE-904B-42F4-8954-D80D53395E3AQ52686292-D37A6B1D-4063-4227-A939-E5A9C089B098Q58608795-878A3B1D-41ED-4A25-82F4-350BBBB8C97E
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Gaucher disease: Progress and ongoing challenges.
@en
Gaucher disease: Progress and ongoing challenges.
@nl
type
label
Gaucher disease: Progress and ongoing challenges.
@en
Gaucher disease: Progress and ongoing challenges.
@nl
prefLabel
Gaucher disease: Progress and ongoing challenges.
@en
Gaucher disease: Progress and ongoing challenges.
@nl
P2093
P2860
P1476
Gaucher disease: Progress and ongoing challenges.
@en
P2093
Ellen Sidransky
Grisel Lopez
Neal J Weinreb
Norman W Barton
Pramod K Mistry
Raphael Schiffmann
P2860
P356
10.1016/J.YMGME.2016.11.006
P577
2016-11-17T00:00:00Z